Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) - (Equine)
| Brand name | Bat |
|---|---|
| Active ingredient | Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) - (Equine) |
| Strength | >4500U |
| Dosage form | Solution |
| Route | Intravenous |
| Modality | Biologic |
| FDA approval | March 2013 |
| Marketing status | Rx |
Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.